AavantiBio
NEWS
AavantiBio was acquired by Solid Biosciences in December 2022.
BioSpace checked in with some of the members of our NextGen Bio Class of 2022 to see what they’ve done to earn their place on the list - and what’s on the horizon.
Solid Biosciences and AavantiBio – announced Friday they are merging to develop a portfolio of neuromuscular and cardiac programs, initially focusing on Duchenne muscular dystrophy.
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
It’s a day of firsts, with the launch of two new Cambridge, Mass.-based life sciences companies.
IN THE PRESS